Raynaud's Phenomenon Related with Atomoxetine Treatment in a Child with Autism and Attention-Deficit/Hyperactivity Disorder

In this article, we report a case of RP in a 7-year-old boy with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) that developed during atomoxetine (ATX) monotherapy as dose dependent and resolved with the discontinuation of medication. Case Presentation B. is a 7-year-old boy with ASD presented with his mother due to behavioral problems, including hyperactivity, impulsivity, and aggressive behaviors toward his peers. According to the report, a 10-year-old girl developed RP soon after a dosage increase and symptoms disappeared when the medication was stopped (Gokcen et al. 2013).